Rahul Baxi cannot catch a break as of late. The Mumbai-based diabetologist’s ready room is buzzing—and it’s the identical story each time somebody steps into his clinic. “Sir woh wajan kam karne ki nayi davai aai hai, woh shuru kar sakte hain kya, weight reduction ke liye?”.
India’s obsession with the brand new ₹16,000-a-month weight-loss injection has formally begun.
“It’s not a magic injection for all,” Dr Baxi shortly clarifies on X. “With out way of life adjustments—sustainable balanced weight loss plan, common stroll/train, power coaching — it could not give the specified outcomes. Utilizing in the best sufferers below medical doctors supervision is the important thing.”
This injection inflicting all the thrill is Mounjaro (Tirzepatide), simply launched by pharmaceutical large Eli Lilly in India, forward of rival Novo Nordisk’s Wegovy. Marketed primarily for diabetes and important weight reduction, it is priced at ₹4,375 for a 5 mg vial, costing sufferers roughly ₹16,000 per 30 days—steep for India, but inexpensive in comparison with its U.S. price of over $1,000 month-to-month.
Dr Manisha Arora, Director at CK Birla Hospital, explains its attraction in an Indian Categorical story: Mounjaro mimics two hormones—GLP-1 and GIP—to manage urge for food, stabilize blood sugar, and gradual digestion, leading to spectacular weight lack of as much as 20 kg in 72 weeks.
However this highly effective injection is not with out dangers. Dr Arora warns clearly: “Frequent unwanted effects are gastrointestinal points such as nausea, vomiting, diarrhoea, and acid reflux disease. In some instances, extreme diarrhea can result in dehydration and acute kidney damage.”
Speedy weight reduction can even result in gallstones and gallbladder irritation.
Who’s a perfect candidate? Adults battling Sort 2 diabetes, these considerably obese, or people with insulin resistance not responding nicely to different therapies. Nonetheless, the drug is off-limits for pregnant girls, kids, Sort 1 diabetics, people with thyroid most cancers historical past, pancreatitis, or extreme gastrointestinal issues.
The craze is not shocking given India’s escalating weight problems and diabetes epidemic.
Diabetes instances may surge to 124 million by 2045, and practically 1 / 4 of Indian adults are already obese or overweight.
Source link
#Sir #woh #wajan #kam #karne #dawai.. #Doctors #flooded #weightloss #jab #hits #India
